Dermapharm Holding SE
XETRA:DMP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Dermapharm Holding SE
XETRA:DMP
|
DE |
|
Konami Holdings Corp
TSE:9766
|
JP |
|
Exor NV
AEX:EXO
|
NL |
|
Telos Corp
NASDAQ:TLS
|
US |
|
AMETEK Inc
NYSE:AME
|
US |
Wall St Price Targets
DMP Price Targets Summary
Dermapharm Holding SE
According to Wall Street analysts, the average 1-year price target for DMP is 41.82 EUR with a low forecast of 34.34 EUR and a high forecast of 50.4 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is DMP's stock price target?
Price Target
41.82
EUR
According to Wall Street analysts, the average 1-year price target for DMP is 41.82 EUR with a low forecast of 34.34 EUR and a high forecast of 50.4 EUR.
What is the Revenue forecast for Dermapharm Holding SE?
Projected CAGR
5%
Over the last 10 years, the compound annual growth rate for Revenue has been 12%. The projected CAGR for the next 5 years is 5%.
What is the Operating Income forecast for Dermapharm Holding SE?
Projected CAGR
7%
Over the last 10 years, the compound annual growth rate for Operating Income has been 13%. The projected CAGR for the next 3 years is 7%.
What is the Net Income forecast for Dermapharm Holding SE?
Projected CAGR
8%
Over the last 10 years, the compound annual growth rate for Net Income has been 26%. The projected CAGR for the next 3 years is 8%.
